Press Releases

 
Press Releases
  Date Title and Summary View
Jun 7, 2002
PITTSBURGH, Jun 7, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE: MYL) announced today that it has reached an agreement with 3M Pharmaceuticals for an exclusive supply and distribution agreement to sell Flecainide Acetate Tablets in bottles of 100 of the 50 mg, 100 mg and 150 mg strengths. In addition, UDL Laboratories, Inc., a Myl...
May 8, 2002
PITTSBURGH, May 8, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. announced today that it has named Wendy Cameron, 42, to its Board of Directors, effective May 2, 2002. Ms. Cameron's appointment increases the Board to 11 members. Ms. Cameron served for 18 years as Vice President, Divisional Sales and Governmental Affairs, for Ca...
May 8, 2002
PITTSBURGH, May 8, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE: MYL) announced today that the Board of Directors has authorized the Company to implement a Stock Repurchase Program pursuant to which the Company may repurchase up to ten million or approximately 8% of its outstanding common shares. These purchases will be made from...
May 8, 2002
PITTSBURGH, May 8, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc.(NYSE: MYL) - Financial Highlights: - Net revenues increased 30% to exceed $1.1 billion for the fiscal year and 14% to $282.6 million for the quarter. - Gross profit increased 63% to $623.9 million for the fisc
May 7, 2002
PITTSBURGH, Pa., May 7, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) today announced that it has established the Mylan Laboratories Charitable Foundation, a 501©(3) non-profit organization dedicated to providing support through grants to other qualified charitable organizations. Mylan es...
Apr 30, 2002
PITTSBURGH, Apr 30, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE: MYL) announced today that it will release its fiscal 2002 fourth quarter and full year financial results before the market opens on Wednesday, May 8, 2002. Mylan management will host a conference call and provide a live webcast later that morning at 10:00 AM EDT to ...
Mar 15, 2002
PITTSBURGH, Mar 15, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) announced today that the regular quarterly cash dividend of four cents per share will be paid on April 15, 2002 to shareholders of record March 29, 2002. CONTACT: Mylan Laboratories Inc., Pittsburgh Patricia Sunseri, 412/232-0100
Mar 5, 2002
PITTSBURGH, Mar 5, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) today announced that it has named Edward J. Borkowski as Chief Financial Officer of the company. Mr. Borkowski joins Mylan from Pharmacia Corporation (NYSE:PHA) where he was most recently Vice President, Global Finance and Information Technology. Previously, Mr....
Mar 5, 2002
PITTSBURGH, Mar 5, 2002 (BUSINESS WIRE) -- Mylan Laboratories Inc. (NYSE:MYL) today is pleased to announce its fiscal 2003 guidance of $2.05 - $2.09. As previously announced, Mylan will host a conference call and Webcast today, at 10:00 AM ET. The dial-in-number to access this call is (913) 981-4900. Because these statements are f...
Page: FirstPrevious ...
106
= add release to Briefcase